Search

How developmental biologist Eric Lai’s approach to science co-evolved with his music, art, and life outside the lab.

… Friday, January 19, 2024 How is a flower like a seashell — and what do they both have in common with math and music? According to Eric Lai, PhD , a developmental biologist at Memorial Sloan Kettering Cancer Center (MSK), mathematical principles are reflected in the repeating patterns we see in biology

Discover some of the latest innovations in chemotherapy for breast cancer.

… Thursday, October 10, 2019 Summary Chemotherapy has come a long way in treating breast cancer. Learn about some of the latest advances.   Chemotherapy has been a mainstay of cancer treatment since the 1940s, and it is still evolving to this day. For people with breast cancer , treatment innovations take

Innovative imaging techniques shed light on intestinal damage that occurs after bone marrow transplant.

… Wednesday, July 17, 2019 VIDEO | 00:38 Mouse Intestinal Tissue This video of mouse intestinal tissue sheds light on graft-versus-host disease. The imaging technique shows clearly for the first time that after bone marrow transplantation the invading T cells from the donor (green) go mainly to the crypt

Meet Jenny Solomon, who uses acting techniques to help people cope with cancer.

… Tuesday, August 28, 2018 Summary Using drama can help people make sense of their emotions in an engaging way. Jenny Solomon shares how theater arts can be a creative outlet for people affected by cancer. Inside the pediatrics inpatient unit at Memorial Sloan Kettering, Gloria Habib had turned into a

Al Roker, anchor of NBC’s TODAY, shared an update on his successful treatment for prostate cancer at MSK in a recent segment on the broadcast. 

… Tuesday, November 17, 2020 Al Roker, anchor of NBC’s TODAY , shared an update on his successful treatment for prostate cancer at Memorial Sloan Kettering (MSK) in a recent segment on the broadcast . Al had previously announced his diagnosis on the show prior to having surgery for the disease. “Al’s surgery

An international group of investigators led by scientists at Memorial Sloan Kettering Cancer Center and the National Cancer Institute has identified a new genetic marker of risk for breast cancer. Women with this DNA variation are at a 1.4 times greater risk of developing breast cancer compared to those without the variation.

… Monday, March 3, 2008 An international group of investigators led by scientists at Memorial Sloan Kettering Cancer Center (MSKCC) and the National Cancer Institute has identified a new genetic marker of risk for breast cancer . Women with this DNA variation are at a 1.4 times greater risk of developing

Learn about the different types of benign breast lumps.

… Friday, May 24, 2024 What should you do if you notice a lump in your breast? Don’t panic. See your doctor. “Many lumps turn out to be benign,” says Memorial Sloan Kettering Cancer Center breast radiologist Kimberly N. Feigin, MD , Acting Chief of Breast Radiology at MSK. “But the most important thing

New data from a study led by Memorial Sloan Kettering physicians that used targeted therapy for patients with the most common type of lung cancer has helped transform treatment for the disease.

… Tuesday, May 20, 2014 Data Supports Routine Tumor Genotyping for Patients with Advanced Lung Cancers; May Improve Survival New data from a study led by Memorial Sloan Kettering physicians that used targeted therapy for patients with the most common type of lung cancer has helped transform treatment for

Immunotherapy pioneers Michel Sadelain, MD, PhD, of Memorial Sloan Kettering Cancer Center (MSK), and Carl June, MD, of the University of Pennsylvania, have published a seminal review of the current landscape of chimeric antigen receptor (CAR) therapy in the New England Journal of Medicine (NEJM). In the comprehensive review article, Drs. Sadelain and June highlight the emerging immunotherapy treatment for hematologic cancers known as CAR T cells, which was developed at MSK. The paper is the first in a series being published by NEJM. Known as Frontiers in Medicine, it will showcase ways that new technologies are influencing contemporary medicine and science.

… Wednesday, July 4, 2018 Immunotherapy pioneers Michel Sadelain, MD, PhD, of Memorial Sloan Kettering Cancer Center (MSK), and Carl June, MD, of the University of Pennsylvania, have published a seminal review of the current landscape of chimeric antigen receptor (CAR) therapy in the New England Journal

Learn how multiple myeloma prognosis has improved significantly with the emergence of new drug treatments.

… Tuesday, January 27, 2026 Note: This story was originally published in 2022 and has been updated. Saad Usmani, MD , a hematologic oncologist specializing in multiple myeloma , is Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center (MSK). Dr. Usmani has more than 15 years of experience